Itay Inbar
@itayinbar.bsky.social
Data scientist @ BRAIN.Q | Computational neuroscience of visual perception @ BGU
3/
This could be the opening of a richer diagnostic pipeline where blood guides classification and neurotech guides personalization. What do you think? 🧠
This could be the opening of a richer diagnostic pipeline where blood guides classification and neurotech guides personalization. What do you think? 🧠
May 18, 2025 at 4:57 PM
3/
This could be the opening of a richer diagnostic pipeline where blood guides classification and neurotech guides personalization. What do you think? 🧠
This could be the opening of a richer diagnostic pipeline where blood guides classification and neurotech guides personalization. What do you think? 🧠
2/
We know people with high amyloid but no symptoms, and others with fast decline and “normal” scans.
That mismatch is where multimodal neurotech shines: tracking cognition, affect, attention, and more.
We know people with high amyloid but no symptoms, and others with fast decline and “normal” scans.
That mismatch is where multimodal neurotech shines: tracking cognition, affect, attention, and more.
May 18, 2025 at 4:57 PM
2/
We know people with high amyloid but no symptoms, and others with fast decline and “normal” scans.
That mismatch is where multimodal neurotech shines: tracking cognition, affect, attention, and more.
We know people with high amyloid but no symptoms, and others with fast decline and “normal” scans.
That mismatch is where multimodal neurotech shines: tracking cognition, affect, attention, and more.